BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34517836)

  • 1. Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.
    van Coller A; Glanzmann B; Cornelissen H; Möller M; Kinnear C; Esser M; Glashoff R
    BMC Immunol; 2021 Sep; 22(1):62. PubMed ID: 34517836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa.
    Cornelissen HM; Glanzmann B; Van Coller A; Engelbrecht C; Abraham DR; Reddy K; Möller M; Kinnear C; Glashoff RH; Esser M
    S Afr Med J; 2021 Oct; 111(10):998-1005. PubMed ID: 34949297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
    Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
    J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India.
    Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM
    Front Immunol; 2021; 12():631298. PubMed ID: 33732252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
    Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S
    Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of molecular diagnosis on treating Mendelian susceptibility to mycobacterial diseases.
    Wang LH; Yen CL; Chang TC; Liu CC; Shieh CC
    J Microbiol Immunol Infect; 2012 Dec; 45(6):411-7. PubMed ID: 23036270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients.
    Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA
    J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of Diagnosing Mendelian Susceptibility to Mycobacterial Diseases in South Africa.
    Scholtz D; Jooste T; Möller M; van Coller A; Kinnear C; Glanzmann B
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
    Nekooie-Marnany N; Deswarte C; Ostadi V; Bagherpour B; Taleby E; Ganjalikhani-Hakemi M; Le Voyer T; Rahimi H; Rosain J; Pourmoghadas Z; Sheikhbahaei S; Khoshnevisan R; Petersheim D; Kotlarz D; Klein C; Boisson-Dupuis S; Casanova JL; Bustamante J; Sherkat R
    J Clin Immunol; 2018 Oct; 38(7):787-793. PubMed ID: 30255293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases.
    Qu HQ; Fisher-Hoch SP; McCormick JB
    Int J Infect Dis; 2011 May; 15(5):e305-13. PubMed ID: 21330176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.
    Errami A; Baghdadi JE; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Rada N; Benajiba N; Mokhantar K; Ouazahrou K; Zaidi S; Abel L; Casanova JL; Boisson-Dupuis S; Bustamante J; Bousfiha AA
    J Clin Immunol; 2023 May; 43(4):728-740. PubMed ID: 36630059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired in-vitro responses to IL-12 and IFN-γ in Iranian patients with Mendelian susceptibility to mycobacterial disease.
    Parvaneh N; Pourakbari B; Rezaei N; Omidvar A; Sabouni F; Mahmoudi S; Khotaei G; Mamishi S
    Allergol Immunopathol (Madr); 2015; 43(5):456-60. PubMed ID: 25201764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe BCG-osis Misdiagnosed as Multidrug-Resistant Tuberculosis in an IL-12Rβ1-Deficient Peruvian Girl.
    Esteve-Sole A; Sánchez-Dávila SP; Deyà-Martínez A; Freeman AF; Zelazny AM; Dekker JP; Khil PP; Holland SM; Noguera-Julian A; Bustamante J; Casanova JL; Juan M; Cordova W; Alsina L
    J Clin Immunol; 2018 Aug; 38(6):712-716. PubMed ID: 30039354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to mycobacterial disease due to mutations in IL-12Rβ1 in three Iranian patients.
    Alinejad Dizaj M; Mortaz E; Mahdaviani SA; Mansouri D; Mehrian P; Verhard EM; Varahram M; Babaie D; Adcock IM; Garssen J; van de Vosse E; Velayati A
    Immunogenetics; 2018 Jun; 70(6):373-379. PubMed ID: 29256176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated review on Mendelian susceptibility to mycobacterial diseases- a silver jubilee celebration of its first genetic diagnosis.
    Das J; Banday AZ; Shandilya J; Sharma M; Vignesh P; Rawat A
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1103-1120. PubMed ID: 34259572
    [No Abstract]   [Full Text] [Related]  

  • 16. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.
    Bustamante J; Boisson-Dupuis S; Abel L; Casanova JL
    Semin Immunol; 2014 Dec; 26(6):454-70. PubMed ID: 25453225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
    Esteve-Solé A; Sologuren I; Martínez-Saavedra MT; Deyà-Martínez À; Oleaga-Quintas C; Martinez-Barricarte R; Martin-Nalda A; Juan M; Casanova JL; Rodriguez-Gallego C; Alsina L; Bustamante J
    Crit Rev Clin Lab Sci; 2018 May; 55(3):184-204. PubMed ID: 29502462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the interleukin-12/interferon-gamma pathway in children with non-tuberculous mycobacterial cervical lymphadenitis.
    Serour F; Mizrahi A; Somekh E; Feinberg J; Picard C; Casanova JL; Dalal I
    Eur J Pediatr; 2007 Aug; 166(8):835-41. PubMed ID: 17120032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mendelian susceptibility to mycobacterial diseases: state of the art.
    Noma K; Mizoguchi Y; Tsumura M; Okada S
    Clin Microbiol Infect; 2022 Nov; 28(11):1429-1434. PubMed ID: 35283318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases.
    Lee WI; Huang JL; Wu TS; Lee MH; Chen IJ; Yu KH; Liu CY; Yang CH; Hsieh MY; Lin YL; Shih YF; Jaing TH; Huang SC; Kuo TT; Ku CL
    Immunobiology; 2013 May; 218(5):762-71. PubMed ID: 23083630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.